A North East firm that has developed a mask to treat people with diabetes in their sleep has secured $10m from a US investor.
PolyPhotonix has created the The Noctura 400 Sleep Mask that can be used to treat diabetic patients who are at risk of losing their sight.
Diabetic retinopathy is a complication of diabetes, which causes high blood sugar levels to damage the back of the eye.